scholarly journals Dehydroepiandrosterone (DHEA) Serum Levels Indicate Cerebrospinal Fluid Levels of DHEA and Estradiol (E2) in Women at Term Pregnancy

Author(s):  
Pardes Habib ◽  
Joseph Neulen ◽  
Shahin Habib ◽  
Benjamin Rösing

AbstractNeuroactive steroids such as dehydroepiandrosterone (DHEA), estradiol (E2), and progesterone (P4) are associated with structural and functional changes in the central nervous system (CNS). Measurement of steroid levels in the CNS compartments is restricted in accessibility. Consequently, there is only limited human data on the distributional equilibrium for steroid levels between peripheral and central compartments. While some neuroactive steroids including DHEA and E2 have been reported to convey excitatory and proconvulsant properties, the opposite was demonstrated for P4. We aimed to elucidate the correlation between peripheral and central DHEA, E2, and P4 levels in women at term pregnancy. CSF and serum samples of 27 healthy pregnant women (22–39 years) at term pregnancy were collected simultaneously under combined spinal and epidural anesthesia and used for DHEA ELISA and E2, and P4 ECLIA. All three neuroactive steroids were detected at markedly lower levels in CSF compared to their corresponding serum concentrations (decrease, mean ± SD, 97.66 ± 0.83%). We found a strong correlation for DHEA between its serum and the corresponding CSF levels (r = 0.65, p = 0.003). Serum and CSF levels of E2 (r = 0.31, p = 0.12) appeared not to correlate in the investigated cohort. DHEA serum concentration correlated significantly with E2 (r = 0.58, p = 0.0016) in CSF. In addition, a strong correlation was found between DHEA and E2, both measured in CSF (r = 0.65, p = 0.0002). Peripheral DHEA levels might serve as an indicator for central nervous levels of the neuroactive steroids DHEA and E2 in pregnant women.

2020 ◽  
Author(s):  
Pardes Habib ◽  
Joseph Neulen ◽  
Shahin Habib ◽  
Benjamin Rösing

Abstract Background and objectives:Neuroactive steroids such as dehydroepiandrosterone (DHEA), estradiol (E2), and progesterone (P4) are associated with structural and functional changes in the central nervous system (CNS). Measurement of steroid levels in the CNS compartments, though restricted in accessibility, is essential for clinical evaluation. Consequently, there is only limited human data on the correlation and equilibrium for steroid levels between peripheral and central compartments. While some neuroactive steroids including DHEA and E2 have been reported to convey excitatory and proconvulsant properties, the opposite was demonstrated for progesterone. We aimed to elucidate the correlation between peripheral and central DHEA, E2, and P4 levels in women at term pregnancy.Subjects and Methods:CSF and serum samples of 27 healthy pregnant women (22-39 years) at term pregnancy were collected simultaneously under combined spinal and epidural anesthesia and used for DHEA, E2, and P4 ELISA.Results:All three neuroactive steroids were detected at markedly lower levels in CSF compared to their corresponding serum concentrations (decrease, mean ± SD, 97.66 ± 0.83 %).We found a strong correlation for DHEA between its serum and the corresponding CSF levels (r=0.65, p=0.003). While a significant but weak correlation (r=0.39, p=0.046) was detected for P4, serum and CSF levels of E2 (r=0.31, p=0.12) appeared not to correlate in the investigated cohort. DHEA serum concentration correlated significantly with both E2 (r=0.58, p=0.0016) and P4 in CSF (r=0.39, p=0.046). A strong correlation between the steroids DHEA and E2 measured in CSF was found (r=0.65, p=0.0002), while no substantial correlation between DHEA and P4 was evident in this compartment (r=0.34, p=0.085). Conclusions: Peripheral DHEA levels might serve as a valid predictor for central nervous levels of the neuroactive steroids DHEA and E2 in pregnant women.


Blood ◽  
2011 ◽  
Vol 118 (21) ◽  
pp. 1644-1644 ◽  
Author(s):  
Jean-Francois Larouche ◽  
Marc Bergeron ◽  
Grace Hampson ◽  
Tim Illidge ◽  
Robert Delage

Abstract Abstract 1644 INTRODUCTION: Rituximab penetration in central nervous system is largely unknown in human. Experiments in monkeys showed that 0,1% of serum rituximab concentration was achieved in cerebrospinal fluid. Reports in patients are limited (Rubenstein JL, Blood 2003 and Petereit HF, Multiple Sclerosis 2009). They demonstrated similar low levels of cerebrospinal fluid penetration with standard dose (375 mg /m2) rituximab in patients with central nervous system (CNS) lymphoma or multiple sclerosis. METHOD: We conducted a phase 2 trial in patients with primary CNS lymphoma. Patients were treated with an intravenous combination of high dose methotrexate (8 g/m2), high dose cytarabine (2 g/m2) and high dose rituximab (750 mg/m2 every 1–2 weeks × 13 infusions). We obtained from four patients paired cerebrospinal fluid and serum samples and rituximab concentration were determined in each. Samples were collected at different time points just before rituximab infusion and represent trough levels. RESULTS: 11 cerebrospinal fluid samples were available and their 11 paired serum samples. Mean cerebrospinal fluid and serum levels were 2,04 ug/mL (0,49–4,08) and 297,09 ug/mL (211,26–504,47) respectively. Mean cerebrospinal fluid levels were 0,71% (0,18–1,5%) of serum levels. No relationship was made between cerebrospinal fluid level and the number of rituximab dose administered. CONCLUSION: In patients with primary CNS lymphoma receiving high dose 1–2 weekly rituximab. cerebrospinal fluid concentration achieve is low compared to serum levels. However, administration of higher dose of intravenous rituximab can increase penetration in central nervous system but its clinical impact is unknown as cerebrospinal fluid levels are still low. Disclosures: No relevant conflicts of interest to declare.


1981 ◽  
Vol 15 (4) ◽  
pp. 284-286 ◽  
Author(s):  
Dennis H. Honda ◽  
Harry G. Adams ◽  
Steven L. Barriere

The concentration of amikacin from simultaneous synovial fluid and serum samples was measured on four separate occasions in a patient treated for Serratia marcescens septic arthritis. Synovial fluid levels were between 12.5 and 24.4 μg/ml, with concurrent serum levels of 12.1–21.0 μg/ml. Parenterally administered amikacin readily distributed into synovial fluid. Failure to eradicate the patient's Serratia septic arthritis with amikacin and daily arthrocentesis may have been a result of inactivation of the antibiotic arising from acidosis occurring in the synovial fluid.


Author(s):  
Bakhodir Kurbanov

This article presents a comparative analysis of morphological and functional changes in the placenta and placental site in pregnant women with various types of hypertensive conditions. The modern ultrastructural methods for the study of the placenta in women with preeclampsia and with a physiological full-term pregnancy have been carried out.


1993 ◽  
Vol 78 (4) ◽  
pp. 562-567 ◽  
Author(s):  
Tiit Mathiesen ◽  
Birger Andersson ◽  
Annika Loftenius ◽  
Hans von Holst

✓ Serum and cerebrospinal fluid (CSF) samples from 12 patients were analyzed for interleukin (IL)-6, soluble IL-2 receptor (1L-2R), and soluble CD8 levels in order to determine the immune activation profile following subarachnoid hemorrhage (SAH). Dramatically increased levels of IL-6 and moderate increases of soluble IL-2R were detected in the CSF in 11 of the 12 patients; slightly elevated levels of soluble CD8 were observed in six patients. The IL-6 levels were higher on Day 6 than on Days 3 and 9. The increases in IL-6, soluble IL-2R, and soluble CD8 levels in the CSF samples were not paralleled by increased values in the serum samples, and thus probably reflected an intrathecal synthesis of the cytokine. Passive transfer of IL-6 across the blood-brain barrier seemed not to occur since the serum and CSF levels of IL-6 showed a negative correlation. The findings suggest a severe inflammatory affection of the central nervous system that could be of importance in understanding the clinical course in patients following SAH.


2015 ◽  
Vol 4 (3) ◽  
Author(s):  
Debby Yolanda ◽  
Ariadi Ariadi ◽  
Nur Indrawati Lipoeto

Abstrak Kehamilan dengan Ketuban Pecah Dini (KPD) masih merupakan masalah penting dalam bidang obstetri, karena berkaitan dengan penyulit atau komplikasi yang dapat meningkatkan morbiditas serta mortalitas maternal dan perinatal. Salah satu faktor risiko KPD yaitu infeksi. C-reactive protein (CRP) merupakan salah satu protein yang meningkat pada saat terjadi infeksi. Tujuan penelitian ini adalah  menentukan perbedaan kadar CRP serum ibu pada kehamilan aterm KPD dan normal. Penelitian ini merupakan penelitian observasional dengan rancangan crosssectional. Dilaksanakan di Ruang Kebidanan RSUD Dr. Achmad Mochtar Bukittinggi tahun 2014. Sampel penelitian ini adalah ibu hamil aterm dengan jumlah 60 orang yang diambil dengan Consecutive Sampling, sampel dibagi menjadi 2 kelompok yaitu ibu hamil ketuban pecah dini dan ibu hamil normal. Pemeriksaan kadar CRP dengan menggunakanmetode ELISA. Data dianalisa menggunakan t-test independent, dan nilai p<0.05 dianggap bermakna secara statistik. Rerata kadar CRP serum pada kelompok KPD adalah 12,40±0,70 dan pada kelompok hamil normal adalah 6,44+2,36. Hasil uji independen t-test menunjukan terdapat perbedaan bermakna rerata kadar CRP serum antara kelompok KPDdengan kelompok kehamilan normal (p<0,05). Kata Kunci: C-reactive protein, ketuban pecah dini, kehamilan normalAbstract Pregnancy with prematur rupture of membrane (PROM) still become an important matter in obstetric, as it relates to complication which can increase maternal and perinatal morbidity and mortality. Infection is one of many risk factors of PROM. C-reactive protein is a protein which elevated when there is an infection. The objective of this study was to determine the difference of maternal C - reactive protein serum levels in term pregnancy with prematur rupture of membrane and normal pregnancy. This is an observational study with cross-sectional design. This study takes place in maternity room of RSUD Dr. Achmad Mochtar Bukittinggi in 2014. Samples in this study are 60 aterm pregnant women which have been chosen by consecutive sampling, samples divided with pregnant women with PROM and normal pregnant women. CRP levels measured with ELISA method. Data were analyzed using analysis ofindependent t-test, and p<0.05 was considered to be significantly different. CRP serum levels mean in term pregnancy with PROM group is 12.40±0.70 and in normal pregnancy group is 6.44+2.36. Independent t-test analysis showed that there was significant difference of maternal C - reactive protein serum levels between in term pregnancy with PROMand normal pregnancy with p value < 0.05. Keywords: C – reactive protein, preterm rupture of membrane, normal pregnancy


2021 ◽  
Author(s):  
Chaelin Lee ◽  
Seung Mi Lee ◽  
Dong Jun Byun ◽  
So Yeon Kim ◽  
Hugh I. Kim ◽  
...  

Abstract Background: Abnormal maternal hypothalamus-pituitary-adrenal axis is associated with fetal growth, and we hypothesized that the alteration in metabolic signatures of cortisol might be detectable during early pregnancy. The objective of this study was to identify predictable maternal serum signatures of cortisol metabolism during the first trimester of women who are expected to deliver small-for-gestational age (SGA) neonates.Methods: This prospective cohort study included 112 pregnant women (with and without SGA, n = 56 each). Maternal serum samples were collected at 10~14 gestational weeks to quantify the levels of cortisol and its precursors and metabolites by liquid chromatography-mass spectrometry.Results: Increased maternal serum levels of tetrahydrocortisol (THF, 11.82 ± 8.16 ng/mL vs. 7.51 ± 2.90 ng/mL, P < 0.005) and decreased 21-deoxycortisol (21-deoxyF, 2.98 ± 1.36 ng/mL vs. 4.33 ± 2.06 ng/mL, P < 0.0001) were observed in pregnant women carrying SGA fetus. In conjunction with individual steroid levels, metabolic ratios corresponding to the activity of related enzymes were calculated. In addition to increased THF/cortisol ratio (P < 0.006), the SGA group showed a significant increase in the two metabolic ratios including cortisol/11-deoxycortisol (F/11-deoxyF; P < 0.03) and cortisol/21-deoxycortisol (F/21-deoxyF; P < 0.0003) indicating cortisol biosynthesis. The ROC curve generated in combination with three variables of 21-deoxyF concentration and two metabolic ratios of F/21-deoxyF and THF/F resulted in AUC = 0.824 (95% confidence interval, 0.713 ~ 0.918). Conclusions: A significant decrease in maternal serum levels of 21-deoxyF and an increase in two metabolic ratios of F/21-deoxyF and THF/F, indicating cortisol biosynthetic rate, represent a reliable biomarker for the prediction of SGA in the first trimester.


2021 ◽  
Author(s):  
Ana Triguero-Martínez ◽  
Emilia Roy-Vallejo ◽  
Eva Tomero ◽  
Nuria Montes ◽  
Hortensia de la fuente ◽  
...  

Abstract Background: Galectin 1 (Gal1) is a lectin highly expressed in immune cells that plays a key immunoregulatory role in autoimmunity and resolution of chronic inflammation. Immune-mediated inflammatory diseases (IMIDs) are a broad group of disorders that share pathogenic mechanisms involving components of acquired and innate immunity. Although IMIDs can develop at onset similar features such as peripheral arthritis, they show differences in their evolution and response to treatments. Therefore, additional diagnostic biomarkers are needed in order to get a better classification of patients with early arthritis, especially those not fulfilling specific classification criteria. In this regard, we have recently described that Gal1 serum levels are increased in rheumatoid arthritis (RA) patients compared to healthy donors (HD). Thus, the objective of this work was to evaluate Gal1 levels in serum and synovial fluid from spondyloarthritis (SpA) patients in comparison with RA patients in order to determine their value as a diagnostic biomarker.Methods: We studied Gal1 levels in serum samples from SpA (n=55) and RA patients (n=52). In addition, 49 HD were studied. We also measured Gal1 synovial fluid levels in RA (n=26), osteoarthritis (OA) (n=26) and peripheral SpA (n=26). In SpA patients, clinical parameters were also collected in order to evaluate their association with Gal1 serum levels. Results: We found that SpA patients showed significantly lower Gal1 serum levels than RA patients and similar levels to the general population. In SpA patients, Gal1 synovial fluid levels were similar to those of OA patients and significantly lower than in RA patients. In addition, we did not find any correlation between Gal1 serum levels and clinical parameters of severity in SpA patients.Conclusions: Our results suggest that Gal1 might be a potential diagnostic biomarker of RA that could allow distinguishing between SpA and RA patients.


2016 ◽  
Vol 2016 ◽  
pp. 1-6 ◽  
Author(s):  
Andréa Tavares Dantas ◽  
Sayonara Maria Calado Gonçalves ◽  
Anderson Rodrigues de Almeida ◽  
Rafaela Silva Guimarães Gonçalves ◽  
Maria Clara Pinheiro Duarte Sampaio ◽  
...  

Objective. To determine active TGF-β1 (aTGF-β1) levels in serum, skin, and peripheral blood mononuclear cell (PBMC) culture supernatants and to understand their associations with clinical parameters in systemic sclerosis (SSc) patients.Methods. We evaluated serum samples from 56 SSc patients and 24 healthy controls (HC). In 20 SSc patients, we quantified spontaneous or anti-CD3/CD28 stimulated production of aTGF-β1 by PBMC. The aTGF-β1 levels were measured by ELISA. Skin biopsies were obtained from 13 SSc patients and six HC, and TGFB1 expression was analyzed by RT-PCR.Results. TGF-β1 serum levels were significantly higher in SSc patients than in HC (p< 0.0001). Patients with increased TGF-β1 serum levels were more likely to have diffuse subset (p= 0.02), digital ulcers (p= 0.02), lung fibrosis (p< 0.0001), positive antitopoisomerase I (p= 0.03), and higher modified Rodnan score (p= 0.046). Most of our culture supernatant samples had undetectable levels of TGF-β1. No significant difference in TGFB1 expression was observed in the SSc skin compared with HC skin.Conclusion. Raised active TGF-β1 serum levels and their association with clinical manifestations in scleroderma patients suggest that this cytokine could be a marker of fibrotic and vascular involvement in SSc.


2021 ◽  
pp. 1-26
Author(s):  
Xue-min Huang ◽  
Yan-hua Liu ◽  
Han Zhang ◽  
Yuan Cao ◽  
Wei-feng Dou ◽  
...  

Abstract The effect of vitamin D (VD) on the risk of preeclampsia (PE) is uncertain. Few of previous studies focused on the relationship between dietary VD intake and PE risk. Therefore, we conducted this 1:1 matched case-control study to explore the association of dietary VD intake and serum VD concentrations with PE risk in Chinese pregnant women. A total of 440 pairs of participants were recruited during March 2016 to June 2019. Dietary information was obtained using a 78-item semi-quantitative food frequency questionnaire. Serum concentrations of 25(OH)D2 and 25(OH)D3 were measured by liquid chromatography–tandem mass spectrometry. Multivariate conditional logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs). Restricted cubic splines (RCS) were plotted to evaluate the dose-response relationship of dietary VD intake and serum VD concentrations with PE risk. Compared with the lowest quartile, the ORs of the highest quartile were 0.45 (95%CI: 0.29-0.71, Ptrend = 0.001) for VD dietary intake and 0.26 (95%CI: 0.11-0.60, Ptrend = 0.003) for serum levels after adjusting for confounders. In addition, the RCS analysis suggested a reverse J-shaped relationship between dietary VD intake and PE risk (P-nonlinearity = 0.02). A similar association was also found between serum concentrations of total 25(OH)D and PE risk (P-nonlinearity = 0.02). In conclusion, this study provides evidence that higher dietary intake and serum levels of VD are associated with the lower risk of PE in Chinese pregnant women.


Sign in / Sign up

Export Citation Format

Share Document